„A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease”. One Health & Risk Management 4, no. 4 (septembrie 29, 2023): 19–26. Data accesării iulie 24, 2026. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374.